GThepharmaceuticalindustryisregulatedworldwideintermsofpatents,priceandproductquality.GInternationalpatentnormsrecogniseproductpatents,andthesenormswouldbebindingonallsignatoriestotheGeneralAgreementonTariffsandTrade(GATT),includingIndia,accordingtothestipulationundertheWorldTradeOrganisation(WTO—thesuccessortoGATT).GIndiarecognisesprocesspatents(asopposedtoproductpatents)undertheIndianPatentA...
Page165ANNEXURESTHEINDIANPHARMACEUTICALINDUSTRYAnnexure1HEALTHCAREINFRASTRUCTUREDISEASEPROFILEININDIAHealthcareInfrastructureThehealthcaresectorinacountryincludesnotonlythedrugsandpharmaceuticalsindustrybutalsothedeliverysystemthatmakesdrugsavailabletothepatient.Thedeliverysystemincludesdoctors,chemists,hospitalsandhealthcarerelatedservices.Ithasbeenobservedthatwithanincreaseinthepenetrationofh...
GThepharmaceuticalmarketcanbedividedintodifferenttherapeuticsegmentsonthebasisofapplication.Therelativesharesofthevarioustherapeuticsegmentsdepend,toagreatextent,onthelevelofeconomicdevelopment,diseaseincidenceandtheavailabilityofhealthcareinfrastructureinacountry.InIndia,anti-infectivesaccountforthelargestmarketshareofabout26%.GThemarketforpharmaceuticalproductsisbroadlydividedintotheethicalse...
GThesizeoftheIndianpharmaceuticalindustryisestimatedatRs.231billion,growingattheannualrateof17%(compoundedannualgrowthrateforFY1996-2001).GTheIndianpharmaceuticalindustryisthefourthlargestgloballyinvolumeterms,andisalmostself-sufficient.However,thegrowthinthebulkdrugssegmenthasbeenhigherthanthatinformulations,primarilybecauseofexports.GTherearearound20,053playersintheIndianpharmaceuticalindustr...
CORPORATEDIGESTIIPartICRAINDUSTRYWATCHSERIESPage214ALEMBICLIMITEDStockChartvaluedofRs.100investedinSensexandCompanyFinancialIndicatorsSector:ValueManufacturingMarketcap:808(Rsmn)Turnover:4739(Rsmn)TotalReturns(%)21.8TotalAssets:3909(Rsmn)ROCE(%)21.7InterimResultsFaceValue10.0MarketPrice11252WkH/L145/60.25BkClsdate30/6/2001P/Eratio3.4FinancialHighlightsListings:NSE,BSE,RegionalFY2002FY2001QTR4QT...